The “Medical Bypass”: new drugs to strike obesity
Pharmaceutical Technology
NOVEMBER 30, 2022
In the US, obesity care is estimated at to cost $147 billion in healthcare spending annually. In the past, obesity medications were often dismissed due to insufficient efficacy data and the fact that they were associated with a high occurrence of side effects.
105 
Let's personalize your content